Sounds like you aren't up to speed with Imagion. Those of us familiar with the company know that producing a general purpose MRI contrast agent, and taking market share from the more risky Gadolinium, could be one of our easiest shots on goal and a huge revenue generator.
IBX Price at posting:
3.3¢ Sentiment: None Disclosure: Held
